
NRC — Imaging, fluorescence and microscopy
- Open continuously
Overview
Fee-for-service imaging, fluorescence and microscopy services including flow cytometry, high throughput DNA, and RNA and protein measurements.
At a glance
Funding available
- Increase performance through digital transformation
- Develop strategic partnerships
- Develop a new product or service
- Varies by project
- Open continuously
Eligible candidates
- Professional, scientific and technical services
- Canada
- Non-profit
- Public or Parapublic institution
- For-profit business
- Sole proprietorship
- All revenue ranges
- All organization sizes
- All groups
- Research
- Business owners / entrepreneurs
- Academia / students
- Fee-for-service model
- All dimensions
Next Steps
Activities funded
The NRC grant for Imaging, Fluorescence, and Microscopy services allows the utilization of advanced technical services to enhance research and technological development. The eligible projects and activities are geared towards leveraging high-end imaging and analytical equipment for scientific and business purposes.
- Engage in high sensitivity multi-color flow cytometry for various cellular analyses including live/dead analysis and apoptosis detection.
- Perform multiplex, rapid quantitative analysis on up to 50 target genes, DNA fragments, RNA, peptides, or proteins using advanced Luminex Magpix systems.
- Conduct time-lapsed imaging of live cell shear flow assays for studies on wound healing, cellular adhesion, and migration using Fluxion BioFlux 200 systems.
- Develop and test new technologies leveraging fee-for-service options for custom research needs.
- Create tailored research plans in partnership with NRC experts to align with specific technology goals, through service or collaborative research arrangements.
Eligibility
Who is eligible?
The grant is designed to support projects that leverage advanced imaging, fluorescence, and microscopy services in their research and development initiatives. Organizations that may apply generally include:- Research institutions engaged in innovative biomedical studies.
- Biotechnology companies focusing on drug development and cellular analysis.
- Academic laboratories requiring advanced cytometric analysis capabilities.
- Healthcare organizations implementing diagnostic innovations through cytometry and imaging.
- Environmental agencies utilizing imaging technologies for ecological assessments.
- Bioengineering firms looking to develop cutting-edge biomaterials or cellular therapies.
Who is not eligible
There are specific types of companies that are not eligible for this grant:
- Companies not engaged in research or technology development
- Companies with no focus on imaging, fluorescence, or microscopy services
Eligible expenses
Eligible projects or activities for this grant involve advanced research and development tasks utilizing cutting-edge imaging, fluorescence, and microscopy services. These initiatives are crucial for enhancing scientific research capabilities and fostering technological innovation in various fields.
- Projects utilizing high sensitivity multi-color flow cytometry for advanced cellular analysis.
- Research involving rapid quantitative analysis of multiple genetic or protein targets with Luminex Magpix system.
- Studies employing time-lapsed imaging of live cellular processes using the Fluxion BioFlux 200 system.
- Development of customized high throughput research plans to meet unique technological needs.
- Collaborative projects aimed at developing new technologies, services, and product lines using specialized technical services.
Additional information
There is no additional relevant information found for this grant.